JP2006520778A5 - - Google Patents

Download PDF

Info

Publication number
JP2006520778A5
JP2006520778A5 JP2006506360A JP2006506360A JP2006520778A5 JP 2006520778 A5 JP2006520778 A5 JP 2006520778A5 JP 2006506360 A JP2006506360 A JP 2006506360A JP 2006506360 A JP2006506360 A JP 2006506360A JP 2006520778 A5 JP2006520778 A5 JP 2006520778A5
Authority
JP
Japan
Prior art keywords
acid
agent
methyl
amino
cephem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006506360A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520778A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2004/000802 external-priority patent/WO2004082719A1/en
Publication of JP2006520778A publication Critical patent/JP2006520778A/ja
Publication of JP2006520778A5 publication Critical patent/JP2006520778A5/ja
Abandoned legal-status Critical Current

Links

JP2006506360A 2003-03-20 2004-03-10 乳房炎及び耳障害を治療するための分散性医薬組成物 Abandoned JP2006520778A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45620103P 2003-03-20 2003-03-20
PCT/IB2004/000802 WO2004082719A1 (en) 2003-03-20 2004-03-10 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders

Publications (2)

Publication Number Publication Date
JP2006520778A JP2006520778A (ja) 2006-09-14
JP2006520778A5 true JP2006520778A5 (cg-RX-API-DMAC7.html) 2007-04-12

Family

ID=33030090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006506360A Abandoned JP2006520778A (ja) 2003-03-20 2004-03-10 乳房炎及び耳障害を治療するための分散性医薬組成物

Country Status (19)

Country Link
US (1) US20040214753A1 (cg-RX-API-DMAC7.html)
EP (1) EP1608406A1 (cg-RX-API-DMAC7.html)
JP (1) JP2006520778A (cg-RX-API-DMAC7.html)
KR (1) KR100765614B1 (cg-RX-API-DMAC7.html)
CN (1) CN1761486A (cg-RX-API-DMAC7.html)
AR (1) AR043651A1 (cg-RX-API-DMAC7.html)
AU (1) AU2004222518A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0408559A (cg-RX-API-DMAC7.html)
CA (1) CA2519589A1 (cg-RX-API-DMAC7.html)
CL (1) CL2004000471A1 (cg-RX-API-DMAC7.html)
CO (1) CO5611165A2 (cg-RX-API-DMAC7.html)
MX (1) MXPA05010019A (cg-RX-API-DMAC7.html)
NO (1) NO20054777L (cg-RX-API-DMAC7.html)
NZ (1) NZ541780A (cg-RX-API-DMAC7.html)
RU (1) RU2321423C2 (cg-RX-API-DMAC7.html)
TW (1) TWI265809B (cg-RX-API-DMAC7.html)
UY (1) UY28236A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004082719A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200506531B (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
MXPA05005995A (es) * 2002-12-02 2006-01-27 Byocoat Entpr Inc Composicion y metodo para tratar una enfermedad fungica en una planta.
AU2004218353C1 (en) * 2003-03-05 2011-02-24 Byocoat Enterprises, Inc. Antimicrobial solution and process
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
MXPA06012215A (es) * 2004-04-22 2007-04-19 Pfizer Prod Inc Metodo de estabilizacion de la sal sodica cefovecina desordenada.
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
SG166115A1 (en) * 2005-09-30 2010-11-29 Boehringer Ingelheim Vetmed Pharmaceutical preparation containing meloxicam
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
AU2007298511B2 (en) * 2006-07-10 2013-03-21 Advanced Enzyme Technologies Limited Compositions for prevention and treatment of mastitis and metritis
BRPI0721211A2 (pt) * 2007-02-08 2013-01-15 Medtronic Xomed Inc uso de um tensoativo e um selante mÉdico, mÉtodo para tratar as condiÇÕes de ouvido, nariz e garganta, e, composiÇço
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
BRPI0700969A (pt) * 2007-03-22 2008-11-04 Ouro Fino Participacoes E Empr composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
WO2009045456A1 (en) * 2007-10-03 2009-04-09 Byocoat Enterprises, Inc. Compositions and methods for treating mastitis
WO2009152374A2 (en) 2008-06-12 2009-12-17 Medtronic Xomed, Inc. Method for treating chronic wounds
US8318817B2 (en) * 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
EP2346324A4 (en) 2008-10-06 2012-10-10 Microbial Defense Systems Llc ANTIMICROBIAL COMPOSITION AND METHODS OF MAKING AND USING
CN101953784B (zh) * 2009-07-16 2012-02-08 中国农业大学 含阿莫西林、硫酸粘菌素和泼尼松龙的兽用混悬液及其制备方法
US9101529B2 (en) 2009-10-12 2015-08-11 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP3456200B1 (en) 2011-05-10 2023-05-03 Next Science IP Holdings Pty Ltd Article having an antimicrobial solid and use thereof
BRPI1103782A2 (pt) * 2011-08-19 2013-07-30 Eurofarma Lab Ltda produto veterinÁrio para tratamento de mastite, pre composiÇço antibiàtica a anti inflamatària, kit, mÉtodo de preparaÇço uso e mÉtodo de tratamento de mastite
CN102784161A (zh) * 2012-08-01 2012-11-21 张吉川 一种治疗急慢性中耳炎的特效滴耳液
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN104825474B (zh) * 2015-04-30 2018-02-06 中国农业科学院兰州畜牧与兽药研究所 一种治疗动物体表损伤的药物组方及其制备工艺
US9987362B2 (en) * 2015-05-06 2018-06-05 Zoetis Services Llc Hydrogel formulation with mild adhesion
US10434097B1 (en) 2015-09-14 2019-10-08 Gateway Biotechnology, Inc. Methods and compositions for treating hearing disorders
JP7217700B2 (ja) 2016-09-13 2023-02-03 アラーガン、インコーポレイテッド 安定化非タンパク質クロストリジウム毒素組成物
CN107252441A (zh) * 2017-08-07 2017-10-17 咸阳职业技术学院 一种治疗奶牛乳腺炎的药物组合物及其制备方法
US11918653B2 (en) * 2017-12-22 2024-03-05 Dompé Farmaceutici S.P.A. Triglyceride otic formulations and uses thereof
EP3934618B1 (en) * 2019-03-06 2026-04-29 Zoetis Services LLC Ready-to-use injectable formulations
JP2022546036A (ja) 2019-08-27 2022-11-02 ケーアイ ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー 疼痛治療に有用な化合物
CN116421731B (zh) * 2023-04-07 2025-09-23 佛山市南海东方澳龙制药有限公司 用于防治奶牛乳房炎的药物组合物及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636194A (en) * 1969-10-23 1972-01-18 Douglas G Parizeau Composition and method for treating mastitis with therapeutic agents
DE2063896A1 (de) * 1970-12-28 1972-07-20 Dynamit Nobel Ag, 5210 Troisdorf Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung
IT1190445B (it) * 1985-11-08 1988-02-16 Fatro Spa Composizioni veterinarie a base di agenti antimicrobici e loro impiego
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
DK0786986T3 (da) * 1994-10-26 2002-04-29 Novartis Ag Anvendelse af en umættet fedtalkohol
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
CA2222138C (en) * 1995-05-25 2008-10-14 G.D. Searle & Co. Method of preparing 3-haloalkyl-1h-pyrazoles
WO1996039146A1 (en) * 1995-06-06 1996-12-12 Bayer Corporation Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
US5756529A (en) * 1995-09-29 1998-05-26 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
AP9700912A0 (en) * 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
GEP20032998B (en) * 1996-04-12 2003-06-25 Searle & Co Substituted Benzenesulfonamide Derivatives as Prodrugs of Cox-2 Inhibitors
RU2156131C1 (ru) * 1996-06-21 2000-09-20 Беляев Юрий Евгеньевич Полуфабрикат для получения основы лекарственного средства, основы лекарственного средства из этого полуфабриката (варианты) и лекарственное средство на этой основе (варианты)
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6307047B1 (en) * 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6440964B1 (en) * 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
AR020660A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en) * 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6676930B2 (en) * 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US7064132B2 (en) * 1999-11-28 2006-06-20 Scientific Development And Research, Inc. Composition and method for treatment of otitis external
JP2003523958A (ja) * 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid
WO2001072298A1 (en) * 2000-03-27 2001-10-04 The General Hospital Corporation Treatments for immune-mediated ear disorders
EP1282435A2 (en) * 2000-05-12 2003-02-12 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
EP1353664A2 (en) * 2000-06-08 2003-10-22 The Board Of Regents, The University Of Texas System Heterocycle derivatives and methods of use for treating anthrax infection
CA2410632A1 (en) * 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions

Similar Documents

Publication Publication Date Title
RU2321423C2 (ru) Диспергируемая фармацевтическая композиция для лечения мастита и ушных расстройств
RU2006101628A (ru) Диспергируемый препарат противовоспалительного агента
TWI262084B (en) Dispersible formulation of an anti-inflammatory agent
KR100666520B1 (ko) 점막 송달을 위한 약제학적 투약형
JP2005517693A (ja) 医薬錠剤
JP4511792B2 (ja) Cox−2阻害剤を含む再構成可能な非経口組成物
JP2004506681A (ja) シクロオキシゲナーゼ−2阻害剤の経口速溶性投薬形態
US20110190252A1 (en) Compositions including clavulanic acid and related methods of use
EP1814517B1 (en) Nonaqueous liquid parenteral aceclofenac formulation
US20120208148A1 (en) Drug alluding dental implant
US20020009421A1 (en) Therapy following skin injury from exposure to ultraviolet radiation
MXPA06001192A (es) Composicion farmaceutica dispersable para el tratamiento de mastitis y trastornos oticos.